Detection of minimal residual disease and persistence of host-type hematopoiesis: a study in 28 patients after sex-mismatched, non-T cell-depleted allogeneic bone …

AH Elmaagacli, HW Becks, DW Beelen… - Bone marrow …, 1995 - europepmc.org
We investigated the persistence of host-type hematopoiesis as defined by mixed chimerism
(MC) in 28 male patients with chronic myelogenous leukemia (CML) who underwent …

Cytogenetic analysis of chimerism and leukemia relapse in chronic myelogenous leukemia patients after T cell-depleted bone marrow transplantation

K Offit, JP Burns, I Cunningham, SC Jhanwar, P Black… - 1990 - ashpublications.org
Serial cytogenetic studies were performed on 64 patients with chronic myelogenous
leukemia (CML) after T cell-depleted allogeneic bone marrow transplantation (BMT). Forty …

Minimal residual disease is more common in patients who have mixed T-cell chimerism after bone marrow transplantation for chronic myelogenous leukemia

S Mackinnon, L Barnett, G Heller, RJ O'Reilly - 1994 - ashpublications.org
Determining both lymphoid chimerism and the presence of minimal residual disease after
allogeneic bone marrow transplantation (BMT) for chronic myelogenous leukemia (CML) …

Donor chimaerism is a strong indicator of disease free survival following bone marrow transplantation for chronic myeloid leukaemia.

N GARDINER, M LAWLER… - Leukemia …, 1997 - search.ebscohost.com
Abstract Although Chronic Myeloid Leukaemia (CML) can be treated successfully with
allogeneic bone marrow transplantation (BMT), leukaemia relapse remains a significant …

Persistent donor chimaerism is consistent with disease-free survival following BMT for chronic myeloid leukaemia

N Gardiner, M Lawler, J O'Riordan, M DeArce… - Bone marrow …, 1997 - nature.com
Chronic myeloid leukaemia (CML) can be treated successfully with allogeneic bone marrow
transplantation (BMT) leading to long-term disease-free survival. Leukemia relapse …

Molecular analysis of lineage-specific chimerism and minimal residual disease by RT-PCR of p210BCR-ABL and p190BCR-ABL after allogeneic bone marrow transplantation …

J Serrano, J Roman, J Sanchez… - Blood, The Journal …, 2000 - ashpublications.org
We studied lineage-specific chimerism and minimal residual disease (MRD) in sequential
posttransplant samples from 55 patients who underwent unmanipulated (n= 44) or partially T …

Relapse after allogeneic bone marrow transplantation for Philadelphia chromosome positive chronic myeloid leukemia: cytogenetic analysis of 24 patients.

A Zaccaria, G Rosti, M Sessarego… - Bone marrow …, 1988 - europepmc.org
One hundred patients with chronic myeloid leukemia (CML) submitted to bone marrow
transplantation (BMT) were included in a cooperative cytogenetic study. Relapse (defined …

Cytogenetic events after bone marrow transplantation for chronic myeloid leukemia in chronic phase

CK Arthur, JF Apperley, AP Guo, F Rassool, LM Gao… - 1988 - ashpublications.org
Forty-eight patients treated by allogeneic bone marrow transplantation (BMT) for
Philadelphia (Ph) chromosome-positive chronic myeloid leukemia in chronic phase had …

Molecular studies of chimerism and minimal residual disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation.

AH Elmaagacli, DW Beelen, HW Becks… - Bone marrow …, 1996 - europepmc.org
We investigated 23 patients for their chimerism status who underwent allogeneic
transplantation using peripheral blood progenitor cells (PBPCT) for chronic myelogenous …

Lymphohaematopoietic chimaerism after bone marrow transplantation for chronic myeloid leukaemia: results of simultaneous cytogenetic analyses on T‐cell colonies …

N Schmitz, B Schlegelberger… - British journal of …, 1991 - Wiley Online Library
Various lymphohaematopoietic compartments represented by cells from T‐cell colonies,
myeloid progenitor cells (CFU‐GM), erythroid progenitor cells (BFU‐E), and bone marrow …